MiSight® 1 day
MiSight® 1 day is safe, well-tolerated, and has the longest and most robust data available on its safety and efficacy of any soft contact lens option for myopia control. It can be considered a first-line treatment for myopia correction and control. It is also the first and currently only myopia control intervention which has received United States FDA indication for myopia control. The MiSight® 1 day dual-focus contact lens has been demonstrated in two randomized clinical trials (two years' and three years' duration) to have a high safety profile, be effective, and well accepted by myopic children. It has the longest dataset available of any myopia controlling soft contact lens, with clinical study results published for up to six years and reported for up to seven years.
Visit the MiSight® 1 day website.
MiSight® 1 day Information
Product disclaimer
FDA Indications for use (US only): MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤0.75 diopters of astigmatism. The lens is to be discarded after each removal.
Availability of interventions with regulatory indications to slow progression of myopia varies by country. CooperVision does not endorse off label prescribing of interventions for myopia control.
Articles on MiSight® 1 day.
Cooper Vision resources
MiSight® 1 day Fitting Guide
Initial trial lens power based on spherical equivalent refraction. Lens wear minimum of 10 hours per day for at least 6 days per week.
How to insert and remove your MiSight® 1 day contact lenses
Learning can be assisted by observing another person do a technique first. Hence, CooperVision has made a simple video to help learn how to insert and remove soft contact lenses for you or your patients to watch.